| GTO ID | GTC1740 |
| Trial ID | NCT03182803 |
| Disease | Advanced Solid Tumor |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor |
| Year | 2017 |
| Country | China |
| Company sponsor | Shanghai Cell Therapy Research Institute |
| Other ID(s) | H2017-02-P01 |
| Cohort 1 | |||||||||||
|
|||||||||||